Tuesday, den 25. November 2008

On September 11, the FDA, Genentech and Biogen Idec (the manufacturers of Rituxan) announced that the labeling for the drug is being revised. This comes after the first report that a patient taking Rituxan to treat rheumatoid arthritis had died of the brain infection progressive multifocal leukoencephalopathy (PML). Rituxan is approved to treat RA and [...]

Tags: , , , , , , , , , , ,

Category: Arthritis | 0 Comments »